Ultrasonic scalpel market seen reaching $3.94 billion by 2030

The Business Research Company says the ultrasonic scalpel market is on track to grow from $2.92 billion in 2025 to $3.12 billion in 2026, driven by minimally invasive surgery, robotic integration and demand for precision tools. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region through 2030.

Why it matters: - Ultrasonic scalpels support procedures that cut and coagulate tissue with less thermal damage, which can reduce blood loss and speed healing. - The market’s growth tracks broader shifts toward minimally invasive and outpatient surgery, both of which affect hospital workflows and patient recovery. - The report’s forecast signals continued demand for advanced surgical tools as healthcare systems invest in precision and efficiency.

What happened: - The Business Research Company published an ultrasonic scalpel market report covering current size, growth drivers, regional trends and future outlook. - The market is projected to rise from $2.92 billion in 2025 to $3.12 billion in 2026, a 6.6% compound annual growth rate. - The market is expected to reach $3.94 billion by 2030, with a 6.0% CAGR over the forecast period. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region through the forecast period. - A free sample of the report and the full market report are available online.

The details: - Ultrasonic scalpels use high-frequency vibrations to cut and coagulate tissue in the same step. - The device is used in laparoscopic and open surgical procedures. - The report links recent growth to rising use of minimally invasive surgery, broader adoption of laparoscopic methods, more advanced surgical tools, higher surgical volumes in hospitals and improved surgeon training. - The forecast also points to deeper integration with robotic surgical systems, demand for energy-efficient instruments, growth in outpatient procedures, efforts to reduce intraoperative blood loss and higher investment in new surgical technologies. - The report says minimally invasive surgery offers smaller incisions, less trauma, shorter hospital stays, lower infection risk, better cosmetic outcomes and faster recovery. - The American Academy of Facial Plastic and Reconstructive Surgery reported that about 83% of surgeries in the U.S. in 2023 were minimally invasive, while 17% were traditional open surgeries. - The American Society of Plastic Surgeons said cosmetic minimally invasive procedures rose from 23.7 million in 2022 to 25.4 million in 2023. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - New 2026 report features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Between the lines: - The report frames ultrasonic scalpels as part of a larger shift toward less invasive and more technology-driven surgery, not just a standalone device category. - Robotics and outpatient care stand out as the next demand drivers, suggesting growth may come as much from care delivery changes as from device innovation. - North America’s lead and Asia-Pacific’s faster growth point to a mature market in one region and a scaling opportunity in another.

What's next: - The market will likely continue expanding if minimally invasive procedures keep taking share from traditional open surgery. - Adoption may rise further as surgical platforms become more robotic and hospitals look for tools that reduce blood loss and operative time. - The Business Research Company is also promoting updates to its 2026 report format, including dashboards and infographics, which may shape how buyers evaluate the category.